A detailed history of Atria Investments LLC transactions in Natera, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 7,691 shares of NTRA stock, worth $1.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,691
Previous 8,407 8.52%
Holding current value
$1.25 Million
Previous $910,000 7.36%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$97.75 - $129.67 $69,989 - $92,843
-716 Reduced 8.52%
7,691 $977,000
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $716,948 - $946,628
8,407 New
8,407 $910,000
Q1 2022

May 02, 2022

SELL
$30.32 - $91.33 $396,221 - $1.19 Million
-13,068 Closed
0 $0
Q4 2021

Feb 04, 2022

SELL
$86.26 - $119.0 $42,612 - $58,786
-494 Reduced 3.64%
13,068 $1.22 Million
Q3 2021

Nov 16, 2021

BUY
$100.17 - $126.36 $286,786 - $361,768
2,863 Added 26.76%
13,562 $1.51 Million
Q2 2021

Aug 10, 2021

BUY
$86.05 - $119.72 $920,648 - $1.28 Million
10,699 New
10,699 $1.22 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.